Yayın:
Application of LC–ESI-MS/MS Method for Analysis of Escitalopram Oxalate in Human Urine and Pharmaceutical Dosage Forms

dc.contributor.authorAtkoşar, Zeki
dc.contributor.authorARLİ, GÖKSEL
dc.contributor.authorŞENER, EROL
dc.contributor.authorErol Şener
dc.contributor.orcid0000-0003-1145-860X
dc.contributor.orcid0000-0003-2559-1196
dc.contributor.orcid0000-0003-1902-4785
dc.date.accessioned2025-11-13T22:24:58Z
dc.date.issued2019-08-22
dc.identifier.doihttps://doi.org/10.1093/chromsci/bmz073
dc.identifier.endpage97
dc.identifier.issn0021-9665
dc.identifier.issue2
dc.identifier.openalexW2989536945
dc.identifier.startpage91
dc.identifier.urihttps://hdl.handle.net/11421/14101
dc.identifier.urihttps://doi.org/10.1093/chromsci/bmz073
dc.identifier.volume58
dc.language.isoen
dc.relation.ispartofJournal of Chromatographic Science
dc.rightsrestrictedAccess
dc.subjectChemistry
dc.subjectChromatography
dc.subjectEscitalopram
dc.subjectUrine
dc.subjectOxalate
dc.subjectOrganic chemistry
dc.subjectPsychology
dc.subjectBiochemistry
dc.subject.sdg6
dc.titleApplication of LC–ESI-MS/MS Method for Analysis of Escitalopram Oxalate in Human Urine and Pharmaceutical Dosage Forms
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5006654353
local.authorid.openalexA5054074736
local.authorid.openalexA5027098601

Dosyalar

Koleksiyonlar